| Literature DB >> 12938570 |
A Cribier1, H Eltchaninoff, C Tron.
Abstract
A percutaneous implantable prosthetic heart valve was developed, and after animal studies, the first human case was performed in a 57-year-old man with calcific aortic stenosis with cardiogenic shock. The implantation was performed with the use of an antegrade trans-septal approach after aortic valvuloplasty, and over a follow-up period of 4 months, the valvular function remained satisfactory. However, severe noncardiac complications occurred leading to death 17 weeks after implantation.Entities:
Mesh:
Year: 2003 PMID: 12938570 DOI: 10.1016/s0003-3928(03)00062-3
Source DB: PubMed Journal: Ann Cardiol Angeiol (Paris) ISSN: 0003-3928